Having published our data on all of the different aspects of clinical improvement that Prostate Artery Embolization (PAE) delivers, we chose next to focus our efforts on making sure PAE gets accepted into the American Urological Association's BPH treatment guidelines. These guidelines are what almost all major insurance companies use to decide what BPH treatments they will cover. Unfortunately, the AUA BPH treatment guidelines have continued to mis-categorize PAE as "experimental" even though there are now over a decade's worth of strong clinical research demonstrating its effectiveness and safety (including previous papers our group has published). These guidelines cite what is in reality a largely unfounded concern about an extraordinarily steep learning curve to master PAE, as well as another unfounded concern about the radiation dose involved in PAE.  In this paper, we were able to demonstrate the learning curve for PAE is no more of an issue than it is with other PAE surgeries that urologists perform, and that a PAE operator who is skilled and knowledgeable can obtain safe and effective results from the beginning.

Interesting case report we put together about successful non-operative management of a rare but known possible risk of a kidney biopsy.